Korea
100+ Global Enterprises Take Advantage of Infosys Living Labs to Accelerate their Digital Innovation Agenda
Infosys Living Labs is delivering digital innovation as-a-service to help them
meet next normal consumer expectations
BENGALURU, India, Aug. 4, 2021 /PRNewswire/ -- Infosys
Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea for Domestic Distribution Rights in Korea for Lamisil®, Lescol® XL and Tegretol®
SEOUL, South Korea, Aug. 3, 2021 /PRNewswire/ -- Yuyu Pharma, a pharmaceutical company based in Korea, and Novartis Korea announced today that the companies have entered into an agreement in which Yuyu will have exclusive distribution rights for the following prescription medicines in Korea: Lami...
Digital New Deal Secures Future Growth Engine
SEOUL, South Korea, Aug. 3, 2021 /PRNewswire/ -- The Born2Global Centre released an article that highlights theKorean Ministry of Science and ICT (MSIT) 's Korean Digital New Deal. As part of the Korean government MSIT, Born2Global Centre has played a crucial role by connecting Korean startups wit...
QueryPie's data governance solution bolsters Hyperconnect, a global social discovery and artificial intelligence company, to safeguard its customers' personal information
SEOUL, South Korea, Aug. 3, 2021 /PRNewswire/ -- QueryPie, a member of
Born2Global Centre, has been selected by Hyperconnect, one of the world's
leading social discovery and video technology companies to strengthen the
company's data governance and meet global privacy regulation standards.
STL collaborates with Facebook Connectivity to develop Evenstar radio units for the Open RAN ecosystem
DALLAS, Aug. 3, 2021 /PRNewswire/ -- STL
Dable partners with IAS to Strengthen Brand Safety Capabilities for Marketers
SEOUL, South Korea, Aug. 3, 2021 /PRNewswire/ -- Dable
UST to Hire Over 10,000 New Employees in 2021
- Company seeks to grow workforce by 40% to meet demand for digital solutions
ALISO VIEJO, Calif., Aug. 3, 2021 /PRNewswire/ -- UST
Mixpanel Ranked as Leader in Asia for G2's Summer 2021 Rankings
Mixpanel, the leading product analytics solution, achieved rankings in 15+ categories and has been named a Leader globally and inAsia for G2's Summer 2021 rankings SEOUL, South Korea, Aug. 3, 2021 /PRNewswire/ -- Mixpanel, the leading product analytics solution, has been ranked in over 15 catego...
MWC21: VisualCamp's eye tracking SDK "SeeSo" wins GLOMO award 2021
BARCELONA, Spain, Aug. 2, 2021 /PRNewswire/ -- VisualCamp, eye tracking software company and a member ofBorn2Global Centre, won "Best Mobile Innovation for Connected Living" at the Global Mobile (GLOMO) Awards at MWC Barcelona 2021 . GSMA judges recognized that SeeSo unlocks new possibilities in a...
Born2Global Centre's collaborative initiative with IDB Lab - $600,000 grant awarded to first cross-continental joint venture partnerships
SEOUL, South Korea, Aug. 2, 2021 /PRNewswire/ -- The outbreak of COVID-19 marked the beginning of an economic turmoil around the world, making overseas business deals and expansions particularly difficult during these socially-isolating times. TheLatin America and the Caribbean (LAC) region has ...
LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic
SEOUL, South Korea, Aug. 1, 2021 /PRNewswire/ -- LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo Clinic to advance LISCure's microbiome therapeutics in non-alcoholic steatohepatitis (NASH). ...
AIRCUVE holds 2FA Security Webinar: Securing Company While Working Remotely
SEOUL, South Korea, Aug. 2, 2021 /PRNewswire/ -- AirCUVE, the global leading network security company, unveiled an intelligent two-factor Authentication Solution, V-FRONT, which is Easy and Powerful Login solution. In COVID-19 Work-From-Home environment, corporate network protection becomes cruci...
Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma
SEOUL, South Korea and SHANGHAI and HONG KONG, Aug. 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics i...
LG Energy Solution gets ambitious with ESG vision
* LG Energy Solution aims to achieve carbon neutral by 2050; convert to 100% renewable energy in its global business operations by 2030. * Leading battery manufacturer boasts efforts to lead sustainable future and declares ESG vision "We CHARGE toward a better future." * "ESG management is a...
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI
* A second joint study conducted by Lunit and Massachusetts General Hospital, published in European Radiology * When used as a second reader, the AI algorithm can enhance effective diagnosis on chest x-ray * With AI, radiology residents were able to recommend 28% more chest CT exams for pot...
STL delivers Cloud-Native OSS/BSS Solution Powered by Microsoft Azure
PUNE, India, July 29, 2021 /PRNewswire/ -- STL
HanAll Biopharma Reports Second Quarter 2021 Results
* Q2'21 sales of KRW 23.4 billion increased 4% from the same period last year * Q2'21 operating profit of KRW 1.6 billion fell slightly by 3% compared to Q2'20 * H1'21 sales of KRW 51.2 billion and operating profit of 6.3 billion grew by 15% and 56% YoY [Business Performance and Financial St...
Infosys to Implement its Cobalt-powered IaaS Solution for Select Portfolio Servicing Inc. in Collaboration with Hitachi Vantara
BENGALURU, India, July 29, 2021 /PRNewswire/ -- Infosys
Daewoong Pharmaceutical Announces Camostat Achieving 50% Faster Recovery Time for Mild COVID-19 Patients Over Age of 50 in Topline Results from Phase 2B Clinical Trial
- Improvement of symptoms such as cough and dyspnea in mild patients over age 50 was reported to be as twice as fast and statistically significant in the treatment group (4 days) compared to the placebo control group (9 days). - Development is underway for potential combination therapies and nove...
Tejas Networks announces a strategic investment from Panatone Finvest Limited, a subsidiary of Tata Sons Private Limited, for a controlling stake in the company
BENGALURU, India, July 29, 2021 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE: TEJASNET) today announced that it has executed definitive agreements with Panatone Finvest Limited ("Panatone"), a subsidiary of Tata Sons Private Limited ("TATA"), which will entail: a) Preferential allotment of...
Week's Top Stories
Most Reposted
DBS crowned Southeast Asia's most valuable brand in Kantar BrandZ 2026 ranking
[Picked up by 307 media titles]
2026-07-15 12:00Visa Reimagines Visa Infinite for Asia Pacific's Modern Affluent
[Picked up by 304 media titles]
2026-07-16 10:00Ascentium Welcomes MGI Dobbyn Carafa, Strengthening Advisory Capability in Australia
[Picked up by 290 media titles]
2026-07-20 15:00Singapore Tourism Board and Traveloka Renew Partnership to Welcome More Southeast Asian and Australian Travellers to Singapore
[Picked up by 287 media titles]
2026-07-17 18:18Klook signs an expanded two-year partnership with Korea Tourism Organization
[Picked up by 287 media titles]
2026-07-16 17:49